Table 2.
Clinical characteristics | Total (N) | Odds ratio in CEP55 expression | p value |
---|---|---|---|
Age (≥65 vs.<65) | 370 | 1.76 (1.16-2.69) | 0.008 |
Gender (female vs. male) | 404 | 0.64 (0.43-0.97) | 0.037 |
Stage (I/II vs. III/IV) | 380 | 1.97 (1.23-3.19) | 0.005 |
Histological grade (G1/G2 vs. G3/G4) | 366 | 3.06 (1.97-4.81) | 9.08 e -7 |
T (T1/T2 vs. T3/T4) | 415 | 1.95 (1.23-3.12) | 0.005 |
N (N0 vs. N1) | 285 | 7.36 (1.29-138.56) | 0.063 |
M (M0 vs. M1) | 300 | 1.34 (029-0.91) | 0.703 |
Survival status (alive vs. dead) | 404 | 1.77 (1.17-2.68) | 0.007 |
Histological type (HCC vs. CCA) | 404 | 18.13 (5.38-112.99) | 8.43 e -5 |
Bold values indicate statistical significance. Abbreviations: HCC: hepatocellular carcinoma; CCA: cholangiocarcinoma.